Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-12-24
1989-12-19
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514410, A61K 3144, A61K 3140
Patent
active
048883476
ABSTRACT:
Specific N-methyl-D-aspartate receptor antagonists are useful in the prevention and treatment of neurodegeneration in various pathological states.
REFERENCES:
patent: 4064139 (1977-12-01), Anderson et al.
patent: 4374838 (1983-02-01), Anderson et al.
patent: 4399141 (1983-08-01), Anderson et al.
patent: 4657899 (1987-04-01), Rzeszotarski et al.
Goodman and Gillman, The Pharmacological Basis of Therapeutics, 5th ed. (1975) pp. 201-211 and 220-221.
The Lancet, pp. 140-143 (1985) Schwarcz et al.
Kemp John A.
Wong Erik H. F.
Woodruff Geoffrey N.
DiPrima Joseph F.
Kearse Richard
Merck Sharp & Dohme Limited
Nicholson William H.
Robinson Douglas W.
LandOfFree
Use of specific N-methyl-D-aspartate receptor antagonists in the does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of specific N-methyl-D-aspartate receptor antagonists in the, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of specific N-methyl-D-aspartate receptor antagonists in the will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1903101